Literature DB >> 28166471

Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.

Heidi J Wehring1, Stephen J Heishman2, Robert P McMahon1, Fang Liu1, Stephanie Feldman1, Heather Raley1, Elaine Weiner1, Deanna L Kelly1.   

Abstract

OBJECTIVE: Nicotine dependence is high in schizophrenia, and craving is known to impact relapse during quit attempts.
METHODS: We compared tobacco craving in smokers with schizophrenia treated with different antipsychotics.
RESULTS: Mean craving scores were lowest in participants receiving first-generation antipsychotics, although these differences were not statistically significant. Craving with clozapine was not lower than with other antipsychotics.
CONCLUSIONS: Further research is needed to determine whether differences in craving exist between antipsychotic classes.

Entities:  

Keywords:  Tobacco; antipsychotic; craving; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28166471      PMCID: PMC5379991          DOI: 10.1080/15504263.2017.1288946

Source DB:  PubMed          Journal:  J Dual Diagn        ISSN: 1550-4271


  44 in total

1.  The effects of dopaminergic D2 stimulation and blockade on smoking behavior.

Authors:  N H Caskey; M E Jarvik; W C Wirshing
Journal:  Exp Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.157

Review 2.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

3.  Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia.

Authors:  Deanna L Kelly; Heather G Raley; Suzanne Lo; Katherine Wright; Fang Liu; Robert P McMahon; Eric T Moolchan; Stephanie Feldman; Charles M Richardson; Heidi J Wehring; Stephen J Heishman
Journal:  Schizophr Bull       Date:  2010-11-01       Impact factor: 9.306

4.  Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.

Authors:  Taro Kishi; Yuki Matsuda; Nakao Iwata; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2013-12       Impact factor: 4.384

5.  Clozapine decreases smoking in patients with chronic schizophrenia.

Authors:  J McEvoy; O Freudenreich; M McGee; C VanderZwaag; E Levin; J Rose
Journal:  Biol Psychiatry       Date:  1995-04-15       Impact factor: 13.382

6.  Predicting smoking relapse with a multidimensional versus a single-item tobacco craving measure.

Authors:  Ivan Berlin; Edward G Singleton; Stephen J Heishman
Journal:  Drug Alcohol Depend       Date:  2013-04-23       Impact factor: 4.492

Review 7.  Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

Authors:  Jose de Leon; Scott C Armstrong; Kelly L Cozza
Journal:  Psychosomatics       Date:  2006 Jan-Feb       Impact factor: 2.386

8.  A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.

Authors:  Amanda Baker; Robyn Richmond; Melanie Haile; Terry J Lewin; Vaughan J Carr; Rachel L Taylor; Sylvia Jansons; Kay Wilhelm
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

9.  Haloperidol antagonism of cue-elicited cocaine craving.

Authors:  S P Berger; S Hall; J D Mickalian; M S Reid; C A Crawford; K Delucchi; K Carr; S Hall
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321

10.  Effects of clozapine on smoking in chronic schizophrenic outpatients.

Authors:  T P George; M J Sernyak; D M Ziedonis; S W Woods
Journal:  J Clin Psychiatry       Date:  1995-08       Impact factor: 4.384

View more
  1 in total

1.  Differential Physical and Mental Benefits of Physiotherapy Program Among Patients With Schizophrenia and Healthy Controls Suggesting Different Physical Characteristics and Needs.

Authors:  Michele Fonseca Szortyka; Viviane Batista Cristiano; Paulo Belmonte-de-Abreu
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.